Epigallocatechin Gallate (EGCG) Improves Anti-Angiogenic State, Cell Viability, and Hypoxia-Induced Endothelial Dysfunction by Downregulating High Mobility Group Box 1 (HMGB1) in Preeclampsia

Min Zhong; Julan Peng; Lanhua Xiang; Xinhuang Yang; Xianghua Wang; Yanbin Zhu

doi:10.12659/MSM.926924

15 October 2020 : Laboratory Research

Epigallocatechin Gallate (EGCG) Improves Anti-Angiogenic State, Cell Viability, and Hypoxia-Induced Endothelial Dysfunction by Downregulating High Mobility Group Box 1 (HMGB1) in Preeclampsia

Min Zhong^1ABCDEFG, Julan Peng^1ABCDEFG, Lanhua Xiang^1ABCDEFG, Xinhuang Yang^1ABCDEFG, Xianghua Wang^1ABCDEFG, Yanbin Zhu^2ABCDEFG*

DOI: 10.12659/MSM.926924

Med Sci Monit 2020; 26:e926924

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 5 EGCG suppressed endothelial dysfunction by downregulating HMGB1. (A) NO levels determined by ELISA assay. (B) p-eNOS and eNOS expression detected by western blot assay. * p<0.05, ** p<0.01, *** p<0.001.

Back to the Article

Epigallocatechin Gallate (EGCG) Improves Anti-Angiogenic State, Cell Viability, and Hypoxia-Induced Endothelial Dysfunction by Downregulating High Mobility Group Box 1 (HMGB1) in Preeclampsia

Your Privacy